---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-065655"
form_type: "8-K"
ticker: "RXST"
cik: "0001111485"
company_name: "RxSight, Inc."
filed_at: "2025-05-07T23:59:59+00:00"
generated_at: "2026-05-22T07:01:00.301771+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# RxSight Q1 revenue $37.9M (+28% YoY); LAL volume up 36%

## Summary
- Q1 revenue $37.9M (+28% YoY); LAL revenue +37%, LDD revenue +8%.
- Net loss $(8.2M) or $(0.20)/share; adjusted net loss $(1.1M) or $(0.03)/share.
- 27,579 LALs sold (+36% YoY); 73 LDDs; installed base 1,044 (+43% YoY).
- Gross margin 74.8% vs 70.1% YoY; cash $229.3M at quarter end.
- Reiterated FY2025 guidance: revenue $160-175M, GM 71-73%, OpEx $150-160M.

## SEC filing metadata
- accession: 0000950170-25-065655
- form_type: 8-K
- ticker: RXST
- cik: 0001111485
- company_name: RxSight, Inc.
- filed_at: 2025-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1111485/000095017025065655/0000950170-25-065655-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1111485/000095017025065655/rxst-20250507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-065655
- JSON: https://secwatch.observer/filing/0000950170-25-065655.json
- Plain text: https://secwatch.observer/filing/0000950170-25-065655.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.